ELECTROMED INC (ELMD) Stock Fundamental Analysis
USA - NYSEARCA:ELMD - US2854091087 - Common Stock
24.81 USD
+0.03 (+0.12%)
24.81 USD
0 (0%)
Taking everything into account, ELMD scores 7 out of 10 in our fundamental rating. ELMD was compared to 190 industry peers in the Health Care Equipment & Supplies industry. ELMD scores excellent points on both the profitability and health parts. This is a solid base for a good stock. ELMD has a correct valuation and a medium growth rate. These ratings would make ELMD suitable for quality investing!
1. Profitability
1.1 Basic Checks
ELMD had positive earnings in the past year.
In the past year ELMD had a positive cash flow from operations.
Each year in the past 5 years ELMD has been profitable.
ELMD had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
ELMD's Return On Assets of 14.01% is amongst the best of the industry. ELMD outperforms 95.26% of its industry peers.
ELMD has a Return On Equity of 17.44%. This is amongst the best in the industry. ELMD outperforms 92.11% of its industry peers.
Looking at the Return On Invested Capital, with a value of 16.69%, ELMD belongs to the top of the industry, outperforming 95.79% of the companies in the same industry.
ELMD had an Average Return On Invested Capital over the past 3 years of 11.76%. This is above the industry average of 8.88%.
The 3 year average ROIC (11.76%) for ELMD is below the current ROIC(16.69%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.01% | ||
| ROE | 17.44% | ||
| ROIC | 16.69% |
ROA(3y)10.26%
ROA(5y)8.54%
ROE(3y)12.47%
ROE(5y)10.29%
ROIC(3y)11.76%
ROIC(5y)9.74%
1.3 Margins
The Profit Margin of ELMD (11.78%) is better than 87.89% of its industry peers.
In the last couple of years the Profit Margin of ELMD has declined.
With an excellent Operating Margin value of 15.43%, ELMD belongs to the best of the industry, outperforming 85.26% of the companies in the same industry.
In the last couple of years the Operating Margin of ELMD has grown nicely.
Looking at the Gross Margin, with a value of 78.08%, ELMD belongs to the top of the industry, outperforming 91.05% of the companies in the same industry.
ELMD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.43% | ||
| PM (TTM) | 11.78% | ||
| GM | 78.08% |
OM growth 3Y29.31%
OM growth 5Y3.56%
PM growth 3Y28.63%
PM growth 5Y-1.68%
GM growth 3Y1.14%
GM growth 5Y0.12%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), ELMD is creating value.
Compared to 1 year ago, ELMD has less shares outstanding
Compared to 5 years ago, ELMD has less shares outstanding
There is no outstanding debt for ELMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 14.89 indicates that ELMD is not in any danger for bankruptcy at the moment.
ELMD has a better Altman-Z score (14.89) than 93.16% of its industry peers.
ELMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 14.89 |
ROIC/WACC1.94
WACC8.62%
2.3 Liquidity
ELMD has a Current Ratio of 4.31. This indicates that ELMD is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of ELMD (4.31) is better than 72.63% of its industry peers.
A Quick Ratio of 3.99 indicates that ELMD has no problem at all paying its short term obligations.
ELMD's Quick ratio of 3.99 is fine compared to the rest of the industry. ELMD outperforms 74.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.31 | ||
| Quick Ratio | 3.99 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 44.83% over the past year.
ELMD shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.82% yearly.
The Revenue has grown by 16.97% in the past year. This is quite good.
Measured over the past years, ELMD shows a quite strong growth in Revenue. The Revenue has been growing by 14.53% on average per year.
EPS 1Y (TTM)44.83%
EPS 3Y47.61%
EPS 5Y17.82%
EPS Q2Q%25%
Revenue 1Y (TTM)16.97%
Revenue growth 3Y15.39%
Revenue growth 5Y14.53%
Sales Q2Q%17.27%
3.2 Future
Based on estimates for the next years, ELMD will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.13% on average per year.
ELMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.48% yearly.
EPS Next Y20.21%
EPS Next 2Y21.56%
EPS Next 3Y10.13%
EPS Next 5YN/A
Revenue Next Year13.69%
Revenue Next 2Y12%
Revenue Next 3Y9.48%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 29.54, the valuation of ELMD can be described as expensive.
ELMD's Price/Earnings ratio is a bit cheaper when compared to the industry. ELMD is cheaper than 74.21% of the companies in the same industry.
ELMD's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.57.
With a Price/Forward Earnings ratio of 24.57, ELMD is valued on the expensive side.
75.79% of the companies in the same industry are more expensive than ELMD, based on the Price/Forward Earnings ratio.
ELMD is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.09, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.54 | ||
| Fwd PE | 24.57 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ELMD is valued a bit cheaper than 77.89% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ELMD indicates a rather cheap valuation: ELMD is cheaper than 87.37% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.75 | ||
| EV/EBITDA | 17.44 |
4.3 Compensation for Growth
ELMD's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of ELMD may justify a higher PE ratio.
PEG (NY)1.46
PEG (5Y)1.66
EPS Next 2Y21.56%
EPS Next 3Y10.13%
5. Dividend
5.1 Amount
ELMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
24.81
+0.03 (+0.12%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners52.56%
Inst Owner Change0.16%
Ins Owners7.82%
Ins Owner Change1.69%
Market Cap207.91M
Revenue(TTM)64.00M
Net Income(TTM)7.54M
Analysts82
Price Target35.7 (43.89%)
Short Float %3.86%
Short Ratio3.48
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.03%
Min EPS beat(2)2.94%
Max EPS beat(2)13.12%
EPS beat(4)4
Avg EPS beat(4)114.69%
Min EPS beat(4)2.94%
Max EPS beat(4)422.88%
EPS beat(8)7
Avg EPS beat(8)66.61%
EPS beat(12)9
Avg EPS beat(12)56.43%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)0.06%
Min Revenue beat(2)-2.37%
Max Revenue beat(2)2.49%
Revenue beat(4)3
Avg Revenue beat(4)2.7%
Min Revenue beat(4)-2.37%
Max Revenue beat(4)6.52%
Revenue beat(8)4
Avg Revenue beat(8)0.39%
Revenue beat(12)6
Avg Revenue beat(12)0.71%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1.94%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.5%
EPS NY rev (1m)2.3%
EPS NY rev (3m)1.54%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 29.54 | ||
| Fwd PE | 24.57 | ||
| P/S | 3.25 | ||
| P/FCF | 18.75 | ||
| P/OCF | 18.25 | ||
| P/B | 4.81 | ||
| P/tB | 4.85 | ||
| EV/EBITDA | 17.44 |
EPS(TTM)0.84
EY3.39%
EPS(NY)1.01
Fwd EY4.07%
FCF(TTM)1.32
FCFY5.33%
OCF(TTM)1.36
OCFY5.48%
SpS7.64
BVpS5.16
TBVpS5.11
PEG (NY)1.46
PEG (5Y)1.66
Graham Number9.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.01% | ||
| ROE | 17.44% | ||
| ROCE | 22.78% | ||
| ROIC | 16.69% | ||
| ROICexc | 25.78% | ||
| ROICexgc | 26.13% | ||
| OM | 15.43% | ||
| PM (TTM) | 11.78% | ||
| GM | 78.08% | ||
| FCFM | 17.32% |
ROA(3y)10.26%
ROA(5y)8.54%
ROE(3y)12.47%
ROE(5y)10.29%
ROIC(3y)11.76%
ROIC(5y)9.74%
ROICexc(3y)17.46%
ROICexc(5y)14.38%
ROICexgc(3y)18.08%
ROICexgc(5y)14.87%
ROCE(3y)16.06%
ROCE(5y)13.3%
ROICexgc growth 3Y46.82%
ROICexgc growth 5Y11%
ROICexc growth 3Y45.6%
ROICexc growth 5Y10.61%
OM growth 3Y29.31%
OM growth 5Y3.56%
PM growth 3Y28.63%
PM growth 5Y-1.68%
GM growth 3Y1.14%
GM growth 5Y0.12%
F-Score8
Asset Turnover1.19
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 26.11% | ||
| Cap/Sales | 0.48% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 103.16% | ||
| Profit Quality | 147.1% | ||
| Current Ratio | 4.31 | ||
| Quick Ratio | 3.99 | ||
| Altman-Z | 14.89 |
F-Score8
WACC8.62%
ROIC/WACC1.94
Cap/Depr(3y)117.67%
Cap/Depr(5y)133.86%
Cap/Sales(3y)1.59%
Cap/Sales(5y)1.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.83%
EPS 3Y47.61%
EPS 5Y17.82%
EPS Q2Q%25%
EPS Next Y20.21%
EPS Next 2Y21.56%
EPS Next 3Y10.13%
EPS Next 5YN/A
Revenue 1Y (TTM)16.97%
Revenue growth 3Y15.39%
Revenue growth 5Y14.53%
Sales Q2Q%17.27%
Revenue Next Year13.69%
Revenue Next 2Y12%
Revenue Next 3Y9.48%
Revenue Next 5YN/A
EBIT growth 1Y50.01%
EBIT growth 3Y49.21%
EBIT growth 5Y18.61%
EBIT Next Year62.84%
EBIT Next 3Y12.1%
EBIT Next 5YN/A
FCF growth 1Y27.85%
FCF growth 3YN/A
FCF growth 5Y28.06%
OCF growth 1Y25.65%
OCF growth 3YN/A
OCF growth 5Y22.11%